Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Gets Price Target Cut from JPMorgan Chase & Co.
Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its price target trimmed by JPMorgan Chase & Co. from $146.00 to $145.00 in a report published on Thursday,Benzinga reports. The brokerage currently has an overweight rating on the stock. A number of other analysts have also recently weighed in on RYTM. Leerink Partners began coverage on shares […]
18 Oct 06:18 · The Markets Daily